Phase 1b trial Mipasetamab Uzoptirine (ADCT-601-102) dose escalation in patients with advanced bone and soft tissue sarcomas

被引：0
|
作者：
Van Tine, Brian Andrew
Chen, Christopher T.
Moreno, Victor
Davis, Elizabeth J.
de Miguel, Maria J.
Italiano, Antoine
Saada-Bouzid, Esma
Milhem, Mohammed
Valverde, Claudia
Chawla, Sant P.
Naqash, Abdul Rafeh
Carter, Louise
Jones, Robin
Conti, Ilaria
Boni, Joe
Havenith, Karin
LeBruchec, Yvan
Pantano, Serafino
Blay, Jean-Yves
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-CT059
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT059
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Phase II Trial of Topotecan by Continuous Infusion in Patients with Advanced Soft Tissue Sarcomas, a SWOG Study
    G. Thomas Budd
    Cathryn Rankin
    Laura F. Hutchins
    Lucas Wong
    Paul J. Petruska
    Karen Antman
    Investigational New Drugs, 2002, 20 : 129 - 132
  • [22] Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas - Results of a phase II trial
    Dileo, Palma
    Morgan, Jeffrey A.
    Zahrieh, David
    Desai, Jayesh
    Salesi, Jeanine M.
    Harrnon, David C.
    Quigley, M. Travis
    Polson, Kathleen
    Demetri, George D.
    George, Suzanne
    CANCER, 2007, 109 (09) : 1863 - 1869
  • [23] Phase II trial of topotecan by continuous infusion in patients with advanced soft tissue sarcomas, a SWOG study
    Budd, GT
    Rankin, C
    Hutchins, LF
    Wong, L
    Petruska, PJ
    Antman, K
    INVESTIGATIONAL NEW DRUGS, 2002, 20 (01) : 129 - 132
  • [24] A Phase 1B/2 Study of Aldoxorubicin in Patients With Soft Tissue Sarcoma
    Chawla, Sant P.
    Chua, Victoria S.
    Hendifar, Andrew F.
    Quon, Doris V.
    Soman, Neelesh
    Sankhala, Kamalesh K.
    Wieland, D. Scott
    Levitt, Daniel J.
    CANCER, 2015, 121 (04) : 570 - 579
  • [25] Safety and Efficacy of the Combination Lurbinectedin plus Doxorubicin from a Phase 1b Trial in Patients with Advanced/Metastatic Soft-Tissue Sarcoma
    Cote, Gregory M.
    Haddox, Candace L.
    Choy, Edwin
    Merriam, Priscilla A.
    Mazzola, Emanuele
    Venkataraman, Vinayak
    Alcindor, Thierry
    Wagner, Andrew J.
    Demetri, George D.
    George, Suzanne
    CLINICAL CANCER RESEARCH, 2024, 30 (13) : 2702 - 2708
  • [26] A phase 1b dose-escalation trial of erlotinib, capecitabine and oxaliplatin in metastatic colorectal cancer (MCRC) patients.
    Delord, JP
    Beale, P
    Van Cutsem, E
    Clarke, S
    Verslype, C
    Bugat, R
    Rakhit, A
    Fettner, S
    Brennscheidt, U
    Feyereislova, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 266S - 266S
  • [27] Phase 1 dose escalation trial of TAS-102 (trifluridine/tipiracil) and temozolomide in the treatment of advanced neuroendocrine tumors
    Uboha, Nataliya V.
    Lubner, Sam J.
    LoConte, Noelle K.
    Mulkerin, Daniel L.
    Eickhoff, Jens C.
    Deming, Dustin A.
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (05) : 1520 - 1525
  • [28] Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas -: A phase II trial by the Spanish Group for Research on Sarcomas (GEIS)
    Maurel, J
    Fra, J
    López-Pousa, A
    del Muro, XG
    Balañá, C
    Casado, A
    Martín, J
    Martínez-Trufero, J
    de las Peñas, R
    Buesa, JM
    CANCER, 2004, 100 (07) : 1498 - 1506
  • [29] Phase 1 dose escalation trial of TAS-102 (trifluridine/tipiracil) and temozolomide in the treatment of advanced neuroendocrine tumors
    Nataliya V. Uboha
    Sam J. Lubner
    Noelle K. LoConte
    Daniel L. Mulkerin
    Jens C. Eickhoff
    Dustin A. Deming
    Investigational New Drugs, 2020, 38 : 1520 - 1525
  • [30] TREATMENT OF ADVANCED SOFT-TISSUE SARCOMAS WITH CHLOROZOTOCIN - A PHASE-II TRIAL OF THE EORTC-SOFT TISSUE-AND-BONE-SARCOMA-GROUP
    MOURIDSEN, HT
    BRAMWELL, VHC
    LACAVE, J
    METZ, R
    VENDRIK, C
    HILD, J
    MCCREANNEY, J
    SYLVESTER, R
    CANCER TREATMENT REPORTS, 1981, 65 (5-6): : 509 - 511
12345